AJ
Ajay Jassal
About Ajay Jassal
Data last updated:
Ajay Jassal is a Director at Cfs Pharma And Opticals Private Limited (since 2016), Director at Irx Pharmaceuticals Private Limited (since 2025) and Director at Centre For Sight Kakathiya Private Limited (since 2023), and holds 2 more current directorships. The companies operate in Consumer Goods, Pharma and Healthcare. The 4 current companies with reported revenue have a combined latest revenue of ₹157 Cr; the largest is Cfs Pharma And Opticals Private Limited at ₹136 Cr (FY 2025). Earlier, Ajay Jassal was a Director at Rims Designer Optics Private Limited (from 2022) and Director at M M Eyetech Private Limited (from 2022) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 03 Feb 2016 | 2010 | ₹136 Cr (FY 2025) | Active | |
| Director | 28 Feb 2025 | 2020 | ₹11.77 Cr (FY 2025) | Active | |
| Director | 28 Dec 2023 | 2023 | ₹6.21 Cr (FY 2025) | Active | |
| Director | 21 Jul 2023 | 2023 | ₹2.81 Cr (FY 2025) | Active | |
| Director | 05 Apr 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Oct 2022 | 1996 | ₹1.49 Cr (FY 2023) | Amalgamated | |
| Director | 01 Oct 2022 | 1988 | ₹7.35 Cr (FY 2023) | Amalgamated | |
| Director | 26 Oct 2023 | 2006 | ₹4.24 Cr (FY 2024) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ajay Jassal
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ajay Jassal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ajay Jassal
Ajay Jassal currently holds 5 directorships: Cfs Pharma And Opticals Private Limited (Director, since 03 Feb 2016, revenue ₹136 Cr (FY 2025)); Irx Pharmaceuticals Private Limited (Director, since 28 Feb 2025, revenue ₹11.77 Cr (FY 2025)); Centre For Sight Kakathiya Private Limited (Director, since 28 Dec 2023, revenue ₹6.21 Cr (FY 2025)); Centre For Sight Fazili Private Limited (Director, since 21 Jul 2023, revenue ₹2.81 Cr (FY 2025)); Centre For Sight I Max Eye Care Private Limited (Director, since 05 Apr 2024).
Ajay Jassal was first appointed on 03 Feb 2016 as Director at Cfs Pharma And Opticals Private Limited. The most recent appointment on record is 28 Feb 2025 at Irx Pharmaceuticals Private Limited.
The 4 current companies of Ajay Jassal that report revenue have a combined latest revenue of ₹157 Cr: Cfs Pharma And Opticals Private Limited ₹136 Cr (FY 2025); Irx Pharmaceuticals Private Limited ₹11.77 Cr (FY 2025); Centre For Sight Kakathiya Private Limited ₹6.21 Cr (FY 2025); Centre For Sight Fazili Private Limited ₹2.81 Cr (FY 2025).
Ajay Jassal held 3 earlier board appointments: Rims Designer Optics Private Limited (Director, from 01 Oct 2022); M M Eyetech Private Limited (Director, from 01 Oct 2022); Rushabh Eye Hospital & Laser Centre Private Limited (Director, from 26 Oct 2023).
The current boards of Ajay Jassal's companies include Alka Sachdev (Cfs Pharma And Opticals Private Limited), Mahipal Singh Sachdev (Cfs Pharma And Opticals Private Limited), Ritika Sachdev Gupta (Irx Pharmaceuticals Private Limited), Shankar Narang (Irx Pharmaceuticals Private Limited), Karanjit Singh Jasuja (Centre For Sight Kakathiya Private Limited), Neeraja Pokkula (Centre For Sight Kakathiya Private Limited), among others.